Development of acquired immunity to Salmonella

Journal of Medical Microbiology

Volumn 52, Issue 6, 2003, Pages 453-459

  Mastroeni, Pietro ^a   Ménager, Nathalie ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SALMONELLOSIS VACCINE;

BIOAVAILABILITY; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE COURSE; IMMUNE DEFICIENCY; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA ENTERICA; SALMONELLA TYPHI; SALMONELLOSIS; SEROTYPE; TYPHOID FEVER;

ANIMALS; HUMANS; IMMUNOCOMPROMISED HOST; SALMONELLA; SALMONELLA INFECTIONS; SALMONELLA VACCINES;

EID: 0038095270     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05173-0     Document Type: Review

References (107)

1. Acharya, I. L., Lowe, C. U., Thapa, R. & 10 other authors (1987). Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med 317, 1101-1104.
2. Altare, F., Lammas, D., Revy, P. & 14 other authors (1998). Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest 102, 2035-2040.
3. Berchieri, A., Jr & Barrow, P. A. (1990). Further studies on the inhibition of colonization of the chicken alimentary tract with Salmonella typhimurium by pre-colonization with an avirulent mutant. Epidemiol Infect 104, 427-441.
4. Biozzi, G., Howard, J. G., Halpern, B. N., Stiffel, C. & Mouton, D. (1960). The kinetics of blood clearance of isotopically labelled Salmonella enteritidis by the reticuloendothelial system in mice. Immunology 3, 74-89.
5. Bodey, G. P. (1974). Infections in cancer patients. I. Bacterial infections. Rev Bras Pesqui Med Biol 7, 453-459.
6. Brown, A. & Hormaeche, C. E. (1989). The antibody response to salmonellae in mice and humans studied by immunoblots and ELISA. Microb Pathog 6, 445-454.
7. Cao, Y., Wen, Z. & Lu, D. (1992). Construction of a recombinant oral vaccine against Salmonella typhi and Salmonella typhimurium. Infect Immun 60, 2823-2827.
8. Carter, P. B. & Collins, F. M. (1974). The route of enteric infection in normal mice. J Exp Med 139, 1189-1203.
9. Chakravortty, D., Hansen-Wester, I. & Hensel, M. (2002). Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J Exp Med 195, 1155-1166.
10. Collins, F. M. (1974). Vaccines and cell-mediated immunity. Bacteriol Rev 38, 371-402.
11. Cooke, E. M. (1990). Epidemiology of foodborne illness: UK. Lancet 336, 790-793.
12. Cookson, B. T. & Bevan, M. J. (1997). Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice. J Immunol 158, 4310-4319.
13. Cooper, G. L. & Thorns, C. J. (1996). Evaluation of SEF14 fimbrial dot blot and flagellar western blot tests as indicators of Salmonella enteritidis infection in chickens. Vet Rec 138, 149-153.
14. Cooper, G. L., Venables, L. M., Woodward, M. J. & Hormaeche, C. E. (1994). Vaccination of chickens with strain CVL30, a genetically defined Salmonella enteritidis aroA live oral vaccine candidate. Infect Immun 62, 4747-4754.
15. Curnutte, J. T., Scott, P. J. & Mayo, L. A. (1989). Cytosolic components of the respiratory burst oxidase: resolution of four components, two of which are missing in complementing types of chronic granulomatous disease. Proc Natl Acad Sci U S A 86, 825-829.
16. de Jong, R., Altare, F., Haagen, I. A. & 9 other authors (1998). Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280, 1435-1438.
17. Dunlap, N. E., Benjamin, W. H., Jr, McCall, R. D., Jr, Tilden, A. B. & Briles, D. E. (1991). A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice. Microb Pathog 10, 297-310.
18. Dunstan, S. J., Stephens, H. A., Blackwell, J. M. & 10 other authors (2001a). Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J Infect Dis 183, 261-268.
19. Dunstan, S. J., Ho, V. A., Duc, C. M. & 12 other authors (2001b). Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1. J Infect Dis 183, 1156-1160.
20. Eisenstein, T. K., Killar, L. M., Stocker, B. A. & Sultzer, B. M. (1984a). Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/HeJ mice. J Immunol 133, 958-961.
21. Eisenstein, T. K., Killar, L. M. & Sultzer, B. M. (1984b). Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. J Infect Dis 150, 425-435.
22. Galdiero, M., De Martino, L., Marcatili, A., Nuzzo, I., Vitiello, M. & Cipollaro de l'Ero, G. (1998). Th1 and Th2 cell involvement in immune response to Salmonella typhimurium porins. Immunology 94, 5-13.
23. Gotuzzo, E., Frisancho, O., Sanchez, J., Liendo, G., Carrillo, C., Black, R. E. & Morris, J. G., Jr (1991). Association between the acquired immunodeficiency syndrome and infection with Salmonella typhi or Salmonella paratyphi in an endemic typhoid area. Arch Intern Med 151, 381-382.
24. - Salmonella typhimurium vaccines in the murine typhoid model. Immunology 90, 618-625.
25. + TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J Immunol 156, 3321-3326.
26. Hohmann, E. L. (2001). Nontyphoidal salmonellosis. Clin Infect Dis 32, 263-269.
27. Hopkins, S. A. & Kraehenbuhl, J. P. (1997). Dendritic cells of the murine Peyer's patches colocalize with Salmonella typhimurium avirulent mutants in the subepithelial dome. Adv Exp Med Biol 417, 105-109.
28. Hormaeche, C. E. (1990). Dead salmonellae or their endotoxin accelerate the early course of a Salmonella infection in mice. Microb Pathog 9, 213-218.
29. Hormaeche, C. E., Fahrenkrog, M. C., Pettifor, R. A. & Brock, J. (1981). Acquired immunity to Salmonella typhimurium and delayed (footpad) hypersensitivity in BALB/c mice. Immunology 43, 547-554.
30. Hormaeche, C. E., Harrington, K. A. & Joysey, H. S. (1985). Natural resistance to salmonellae in mice: control by genes within the major histocompatibility complex. J Infect Dis 152, 1050-1056.
31. - Salmonella live vaccines. Microb Pathog 10, 149-158.
32. Hormaeche, C. E., Mastroeni, P., Harrison, J. A., Demarco de Hormaeche, R., Svenson, S. & Stocker, B. A. (1996). Protection against oral challenge three months after i.v. immunization of BALB/c mice with live aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen. Vaccine 14, 251-259.
33. Ivanhoff, B. (1995). Typhoid fever, global situation and WHO recommendations. Southeast Asian J Trop Med Public Health 26 (Suppl. 2), 1-6.
34. Kantele, A., Arvilommi, H. & Jokinen, I. (1986). Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J Infect Dis 153, 1126-1131.
35. Kantele, A., Arvilommi, H., Kantele, J. M., Rintala, L. & Makela, P. H. (1991). Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi Ty21a vaccines. Microb Pathog 10, 117-126.
36. Killar, L. M. & Eisenstein, T. K. (1984). Differences in delayed-type hypersensitivity responses in various mouse strains in the C3H lineage infected with Salmonella typhimurium, strain SL3235. J Immunol 133, 1190-1196.
37. Killar, L. M. & Eisenstein, T. K. (1986). Delayed-type hypersensitivity and immunity to Salmonella typhimurium. Infect Immun 52, 504-508.
38. Klugman, K. P., Koornhof, H. J., Robbins, J. B. & Le Cam, N. N. (1996). Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 14, 435-438.
39. Kossaczka, Z., Lin, F.Y., Ho, V. A. & 11 other authors (1999). Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect Immun 67, 5806-5810.
40. Kuusi, N., Nurminen, M., Saxen, H., Valtonen, M. & Makela, P. H. (1979). Immunization with major outer membrane proteins in experimental salmonellosis of mice. Infect Immun 25, 857-862.
41. Levine, M. M., Ferreccio, C., Black, R. E., Tacket, C. O. & Germanier, R. (1989). Progress in vaccines against typhoid fever. Rev Infect Dis 11 (Suppl. 3), S552-S567.
42. Liang-Takasaki, C. J., Saxen, H., Makela, P. H. & Leive, L. (1983). Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect Immun 41, 563-569.
43. Lin, F. Y., Ho, V. A., Khiem, H. B. & 9 other authors (2001). The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 344, 1263-1269.
44. + T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J Immunol 162, 5398-5406.
45. Lo, W. F., Woods, A. S., DeCloux, A., Cotter, R. J., Metcalf, E. S. & Soloski, M. J. (2000). Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat Med 6, 215-218.
46. + dendritic cells initiating cytokine expression. Eur J Immunol 29, 1107-1115.
47. Maskell, D. J., Hormaeche, C. E., Harrington, K. A., Joysey, H. S. & Liew, F. Y. (1987). The initial suppression of bacterial growth in a Salmonella infection is mediated by a localized rather than a systemic response. Microb Pathog 2, 295-305.
48. Mastroeni, P., Harrison, J. A., Robinson, J. H., Clare, S., Khan, S., Maskell, D. J., Dougan, G. & Hormaeche, C. E. (1998). Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect Immun 66, 4767-4776.
49. -/- (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 68, 46-53.
50. Mastroeni, P., Vazquez-Torres, A., Fang, F. C., Xu, Y., Khan, S., Hormaeche, C. E. & Dougan, G. (2000b). Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 192, 237-248.
51. Mastroeni, P., Chabalgoity, J. A., Dunstan, S. J., Maskell, D. J. & Dougan, G. (2001). Salmonella: immune responses and vaccines. Vet J 161, 132-164.
52. Matsui, K. & Arai, T. (1989). Protective immunity induced by porin in experimental mouse salmonellosis. Microbiol Immunol 33, 699-708.
53. McClelland, M., Sanderson, K. E., Spieth, J. & 23 other authors (2001). Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413, 852-856.
54. McSorley, S. J. & Jenkins, M. K. (2000). Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar Typhimurium. Infect Immun 68, 3344-3348.
55. + T cell responses during natural infection with Salmonella typhimurium. J Immunol 164, 986-993.
56. Mirza, S. H., Beeching, N. J. & Hart, C. A. (1996). Multi-drug resistant typhoid: a global problem. J Med Microbiol 44, 317-319.
57. Mittrucker, H. W., Kohler, A., Mak, T. W. & Kaufmann, S. H. (1999). Critical role of CD28 in protective immunity against Salmonella typhimurium. J Immunol 163, 6769-6776.
58. Mittrucker, H. W., Raupach, B., Kohler, A. & Kaufmann, S. H. (2000). Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J Immunol 164, 1648-1652.
59. Mixter, P. F., Camerini, V., Stone, B. J., Miller, V. L. & Kronenberg, M. (1994). Mouse T lymphocytes that express a gamma delta T-cell antigen receptor contribute to resistance to Salmonella infection in vivo. Infect Immun 62, 4618-4621.
60. Mouy, R. (1989). Chronic septic granulomatosis. Clinical and therapeutic aspects. Ann Pediatr (Paris) 36, 374-378 (in French).
61. Mukkur, T. K., McDowell, G. H., Stocker, B. A. & Lascelles, A. K. (1987). Protection against experimental salmonellosis in mice and sheep by immunisation with aromatic-dependent Salmonella typhimurium. J Med Microbiol 24, 11-19.
62. Murphy, J. R., Wasserman, S. S., Baqar, S., Schlesinger, L., Ferreccio, C., Lindberg, A. A. & Levine, M. M. (1989). Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions. Clin Exp Immunol 75, 228-233.
63. Nauciel, C. & Espinasse-Maes, F. (1992). Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun 60, 450-454.
64. Nauciel, C., Ronco, E., Guenet, J. L. & Pla, M. (1988). Role of H-2 and non-H-2 genes in control of bacterial clearance from the spleen in Salmonella typhimurium-infected mice. Infect Immun 56, 2407-2411.
65. O'Brien, A. D., Metcalf, E. S. & Rosenstreich, D. L. (1982). Defect in macrophage effector function confers Salmonella typhimurium susceptibility on C3H/HeJ mice. Cell Immunol 67, 325-333.
66. Ogunniyi, A. D., Manning, P. A. & Kotlarski, I. (1994). A Salmonella enteritidis 11RX pilin induces strong T-lymphocyte responses. Infect Immun 62, 5376-5383.
67. Ottenhoff, T. H., Kumararatne, D. & Casanova, J. L. (1998). Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today 19, 491-494.
68. Parkhill, J., Dougan, G., James, K. D. & 38 other authors (2001). Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413, 848-852.
69. + major histocompatibility class I-restricted cytotoxic T lymphocytes. Infect Immun 70, 4009-4018.
70. Picard, C., Fieschi, C., Altare, F. & 21 other authors (2002). Inherited interleukin-12 deficiency: IL-12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 70, 336-348.
71. + cytotoxic T lymphocytes following primary and secondary Salmonella infection. Immunology 81, 177-182.
72. Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J. P. & Ricciardi-Castagnoli, P. (2001). Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2, 361-367.
73. Richter-Dahlfors, A., Buchan, A. M. J. & Finlay, B. B. (1997). Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J Exp Med 186, 569-580.
74. Robertsson, J. A., Fossum, C., Svenson, S. B. & Lindberg, A. A. (1982a). Salmonella typhimurium infection in calves: specific immune reactivity against O-antigenic polysaccharide detectable in in vitro assays. Infect Immun 37, 728-736.
75. Robertsson, J. A., Svenson, S. B. & Lindberg, A. A. (1982b). Salmonella typhimurium infection in calves: delayed specific skin reactions directed against the O-antigenic polysaccharide chain. Infect Immun 37, 737-748.
76. + effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J Immunol 169, 2196-2203.
77. Saxen, H., Reima, I. & Makela, P. H. (1987). Alternative complement pathway activation by Salmonella O polysaccharide as a virulence determinant in the mouse. Microb Pathog 2, 15-28.
78. Schafer, R. & Eisenstein, T. K. (1992). Natural killer cells mediate protection induced by a Salmonella aroA mutant. Infect Immun 60, 791-797.
79. Segall, T. & Lindberg, A. A. (1993). Oral vaccination of calves with an aromatic-dependent Salmonella dublin (O9, 12) hybrid expressing O4, 12 protects against S. dublin (O9, 12) but not against Salmonella typhimurium (O4, 5, 12). Infect Immun 61, 1222-1231.
80. Shea, J. E., Hensel, M., Gleeson, C. & Holden, D. W. (1996). Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci U S A 93, 2593-2597.
81. Singh, M., Ganguly, N. K., Kumar, L. & Vohra, H. (1999). Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi. Microbiol Immunol 43, 535-542.
82. Sinha, K., Mastroeni, P., Harrison, J., de Hormaeche, R. D. & Hormaeche, C. E. (1997). Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect Immun 65, 1566-1569.
83. Slauch, J. M., Mahan, M. J. & Mekalanos, J. J. (1994). In vivo expression technology for selection of bacterial genes specifically induced in host tissues. Methods Enzymol 235, 481-492.
84. Stabel, T. J., Mayfield, J. E., Morfitt, D. C. & Wannemuehler, M. J. (1993). Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [Δcya-12 Δ (crp-cdt)19] mutant containing a recombinant plasmid. Infect Immun 61, 610-618.
85. Svenson, S. B., Nurminen, M. & Lindberg, A. A. (1979). Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun 25, 863-872.
86. Svensson, M., Johansson, C. & Wick, M. J. (2000). Salmonella enterica serovar Typhimurium-induced maturation of bone marrow-derived dendritic cells. Infect Immun 68, 6311-6320.
87. Sztein, M. B., Wasserman, S. S., Tacket, C. O., Edelman, R., Hone, D., Lindberg, A. A. & Levine, M. M. (1994). Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis 170, 1508-1517.
88. Sztein, M. B., Tanner, M. K., Polotsky, Y., Orenstein, J. M. & Levine, M. M. (1995). Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J Immunol 155, 3987-3993.
89. Szu, S. C., Stone, A. L., Robbins, J. D., Schneerson, R. & Robbins, J. B. (1987). Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals. J Exp Med 166, 1510-1524.
90. Szu, S. C., Li, X. R., Schneerson, R., Vickers, J. H., Bryla, D. & Robbins, J. B. (1989). Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi. Infect Immun 57, 3823-3827.
91. Taylor, P. D., Inchley, C. J. & Gallagher, M. P. (1998). The Salmonella typhimurium AhpC polypeptide is not essential for virulence in BALB/c mice but is recognized as an antigen during infection. Infect Immun 66, 3208-3217.
92. Thatte, J., Rath, S. & Bal, V. (1993). Immunization with live versus killed Salmonella typhimurium leads to the generation of an IFN-gamma-dominant versus an IL-4-dominant immune response. Int Immunol 5, 1431-1436.
93. Tite, J. P., Dougan, G. & Chatfield, S. N. (1991). The involvement of tumor necrosis factor in immunity to Salmonella infection. J Immunol 147, 3161-3164.
94. Todd, E. (1990). Epidemiology of foodborne illness: North America. Lancet 336, 788-790.
95. Udhayakumar, V. & Muthukkaruppan, V. R. (1987). An outer membrane protein (porin) as an eliciting antigen for delayed-type hypersensitivity in murine salmonellosis. Infect Immun 55, 822-824.
96. Vazquez-Torres, A., Jones-Carson, J., Baumler, A. J. & 7 other authors (1999). Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401, 804-808.
97. Vazquez-Torres, A., Xu, Y., Jones-Carson, J., Holden, D. W., Lucia, S. M., Dinauer, M. C., Mastroeni, P. & Fang, F. C. (2000). Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287, 1655-1658.
98. Vazquez-Torres, A., Fantuzzi, G., Edwards, C. K., III, Dinarello, C. A. & Fang, F. C. (2001). Defective localization of the NADPH phagocyte oxidase to Salmonella-containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages. Proc Natl Acad Sci U S A 98, 2561-2565.
99. Vidal, S. M., Malo, D., Vogan, K., Skamene, E. & Gros, P. (1993). Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73, 469-485.
100. Vordermeier, H. M. & Kotlarski, I. (1990a). Identification of antigens which stimulate T lymphocytes of Salmonella enteritidis 11RX immunized mice. Immunol Cell Biol 68, 299-305.
101. Vordermeier, H. M. & Kotlarski, I. (1990b). Partial purification and characterization of low molecular weight antigens of Salmonella enteritidis 11RX. Immunol Cell Biol 68, 307-316.
102. Vordermeier, H. M., Pope, M. & Kotlarski, I. (1990). Presentation of Salmonella antigens by peritoneal cells of normal and Salmonella-infected mice. Immunol Cell Biol 68, 161-172.
103. Warren, J., Mastroeni, P., Dougan, G., Noursadeghi, M., Cohen, J., Walport, M. J. & Botto, M. (2002). Increased susceptibility of C1q-deficient mice to Salmonella enterica serovar Typhimurium infection. Infect Immun 70, 551-557.
104. Watson, D. C., Robbins, J. B. & Szu, S. C. (1992). Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine. Infect Immun 60, 4679-4686.
105. Weintraub, B. C., Eckmann, L., Okamoto, S., Hense, M., Hedrick, S. M. & Fierer, J. (1997). Role of αβ and γδ T cells in the host response to Salmonella infection as demonstrated in T-cell-receptor-deficient mice of defined Ity genotypes. Infect Immun 65, 2306-2312.
106. Xu, H. R., Hsu, H. S., Moncure, C. W. & King, R. A. (1993). Correlation of antibody titres induced by vaccination with protection in mouse typhoid. Vaccine 11, 725-729.
107. Yrlid, U., Svensson, M., Hakansson, A., Chambers, B. J., Ljunggren, H. G. & Wick, M. J. (2001). In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection. Infect Immun 69, 5726-5735.